You need to upgrade your Flash Player

DENDREON CORP (DNDN) 28.01 red arrow -$0.04 (-0.14%) 09:27PM (15 mins delay)


Stock Picks

stock pick type Short Term For The Long Haul
Posted 161 days ago on 6/12/09 by David Moore

Dendreon Corp is the type of investment that will only grow with new discoveries. This discovery door has been opened with the FDA approval of a cancer drug that will drop the number of deaths due to...

Read complete stock pick on DNDN

stock pick type What You Should Know About DNDN and Provenge
Posted 203 days ago on 5/01/09 by Seth Klotz

1) FDA approval: DNDN's Provenge met and exceeded all FDA-stated requirements for approval. The most recent trial results constitute conclusive proof that Provenge works, and the FDA WILL approve the...

Read complete stock pick on DNDN

stock pick type No earnings power until Provenge hits market
Posted 514 days ago on 6/23/08 by Roman Sosalski

DNDN is an innovative company that developed Provenge to combat prostate cancer. It has been voted 17-0 as safe, but 13-4 to meet the guidelines of congressional approval. The 4 no votes had conflict...

Read complete stock pick on DNDN

stock pick type A risk. but a good buy
Posted 533 days ago on 6/05/08 by Bob Morrissey

alright, so we have another pharmacy stock. right off the bad its gonna be volatile. they have this drug called provenge that is supposed to help people with prostate. did well in the lab, did well on...

Read complete stock pick on DNDN

stock pick type Fight against cancer
Posted 580 days ago on 4/19/08 by Dan Bart

Dendreon Corporation is developing new ways and medicines against prostate cancer and other forms of cancer. With these new and effective medicines, the stock will no doubt increase. DNDN is supposedly...

Read complete stock pick on DNDN

Subscribe to Stock Picks feed:
Displaying 1 - 5 of 8


Make a suggestion for this page

Investing Channel Logo

Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.